Cargando…
Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems
The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadv...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781429/ https://www.ncbi.nlm.nih.gov/pubmed/36559176 http://dx.doi.org/10.3390/pharmaceutics14122681 |
_version_ | 1784857072107520000 |
---|---|
author | Jampilek, Josef Kralova, Katarina |
author_facet | Jampilek, Josef Kralova, Katarina |
author_sort | Jampilek, Josef |
collection | PubMed |
description | The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadvantages of natural compounds, especially essential oils, are their instability, limited bioavailability, volatility, and often irritant/allergenic potential. However, these active substances can be stabilized by encapsulation and administered in the form of nanoparticles. This brief overview summarizes the latest results of the application of nanoemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers used as drug delivery systems of herbal essential oils or used directly for their individual secondary metabolites applicable in cancer therapy. Although the discussed bioactive agents are not typical compounds used as anticancer agents, after inclusion into the aforesaid formulations improving their stability and bioavailability and/or therapeutic profile, they indicated anti-tumor activity and became interesting agents with cancer treatment potential. In addition, co-encapsulation of essential oils with synthetic anticancer drugs into nanoformulations with the aim to achieve synergistic effect in chemotherapy is discussed. |
format | Online Article Text |
id | pubmed-9781429 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-97814292022-12-24 Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems Jampilek, Josef Kralova, Katarina Pharmaceutics Review The use of natural compounds is becoming increasingly popular among patients, and there is a renewed interest among scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly in the form of teas/decoctions/infusions or as standardized extracts. However, the disadvantages of natural compounds, especially essential oils, are their instability, limited bioavailability, volatility, and often irritant/allergenic potential. However, these active substances can be stabilized by encapsulation and administered in the form of nanoparticles. This brief overview summarizes the latest results of the application of nanoemulsions, liposomes, solid lipid nanoparticles, and nanostructured lipid carriers used as drug delivery systems of herbal essential oils or used directly for their individual secondary metabolites applicable in cancer therapy. Although the discussed bioactive agents are not typical compounds used as anticancer agents, after inclusion into the aforesaid formulations improving their stability and bioavailability and/or therapeutic profile, they indicated anti-tumor activity and became interesting agents with cancer treatment potential. In addition, co-encapsulation of essential oils with synthetic anticancer drugs into nanoformulations with the aim to achieve synergistic effect in chemotherapy is discussed. MDPI 2022-12-01 /pmc/articles/PMC9781429/ /pubmed/36559176 http://dx.doi.org/10.3390/pharmaceutics14122681 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Jampilek, Josef Kralova, Katarina Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title | Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title_full | Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title_fullStr | Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title_full_unstemmed | Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title_short | Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems |
title_sort | anticancer applications of essential oils formulated into lipid-based delivery nanosystems |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781429/ https://www.ncbi.nlm.nih.gov/pubmed/36559176 http://dx.doi.org/10.3390/pharmaceutics14122681 |
work_keys_str_mv | AT jampilekjosef anticancerapplicationsofessentialoilsformulatedintolipidbaseddeliverynanosystems AT kralovakatarina anticancerapplicationsofessentialoilsformulatedintolipidbaseddeliverynanosystems |